ROR1 and neoplasm: Additional limitations included lack of correlation of response with baseline ROR1 level, lack of ROR1 gene expression assayed in tumor specimens, and lack of consensus of which antibodies are best suited for detection of ROR1 on formalin-fixed cancer tissue.